Journal article
Brexpiprazole versus placebo or other antidepressive agents for treating depression
- Abstract:
-
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute‐ and long‐term treatment of major depression.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, 179.2KB, Terms of use)
-
- Publisher copy:
- 10.1002/14651858.CD013866
Authors
- Publisher:
- Cochrane Collaboration
- Journal:
- Cochrane Database of Systematic Reviews More from this journal
- Volume:
- 2021
- Issue:
- 2
- Article number:
- CD013866
- Publication date:
- 2021-02-05
- DOI:
- EISSN:
-
1469-493X
- Language:
-
English
- Keywords:
- Pubs id:
-
1169684
- Local pid:
-
pubs:1169684
- Deposit date:
-
2021-10-22
Terms of use
- Copyright holder:
- Cochrane Collaboration.
- Copyright date:
- 2021
- Rights statement:
- © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
If you are the owner of this record, you can report an update to it here: Report update to this record